Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLUE: CLinical Utility Study of EsoGuard on Samples Collected Using EsoCheck as a Triage Test for Endoscopy to Identify Barrett's Esophagus (BE)

NCT06030180 is registered in ClinicalTrials.gov with Lucid Diagnostics, Inc. as lead sponsor.

NCT NCT06030180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06030180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLUE: CLinical Utility Study of EsoGuard on Samples Collected Using EsoCheck as a Triage Test for Endoscopy to Identify Barrett's Esophagus (BE)
Lead sponsor
Lucid Diagnostics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 23, 2023
Completion date
December 13, 2024
Enrollment
566 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, barretts esophagus with dysplasia, esophagus adenocarcinoma